| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |